InsiderTrades

Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.

Accepted 2026-08-14 17:10:26 ET · period of report 2026-08-12 · accession 0001804567-26-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-14 17:10 2026-08-12 SUPN Mottola Frank SVP, Chief Tech. Ops. Off M - OptEx $0.00 +1,650 20.3K +9% $0
D 2026-08-14 17:10 2026-08-12 SUPN Mottola Frank SVP, Chief Tech. Ops. Off F - Tax $46.57 -797 19.5K -4% -$37.1K
D 2026-08-14 17:10 2026-08-12 SUPN Mottola Frank SVP, Chief Tech. Ops. Off M - OptEx $0.00 -1,650 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-12 M A 1,650 $0.00 20,341 D — — (F1) Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
2 Common Common Stock 2026-08-12 F D 797 $46.57 19,544 D — — (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
3 Derivative Performance Share Unit 2026-08-12 M D 1,650 $0.00 0 D $0.00 · — to — 1,650 Common Stock (F3) On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025. (F3) On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.